Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
Cancer Treatment and Research Communications|September 15, 2020
Radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma: A retrospective, multi-center studyJanesh Lakhoo, Ryan Adams, Atman Dave, et al.Academic Radiology|April 18, 2015
Contrast-Enhanced Subharmonic and Harmonic Ultrasound of Renal Masses Undergoing Percutaneous CryoablationJohn R Eisenbrey, Colette M Shaw, Andrej Lyshchik, et al.Journal of Vascular and Interventional Radiology : JVIR|June 17, 2024
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver MalignancyAndrew S Kennedy, Daniel B Brown, Marwan Fakih, et al.Journal of Vascular and Interventional Radiology : JVIR|August 28, 2023
Predictive Partition Dosimetry and Outcomes after Yttrium-90 Resin Microsphere Radioembolization of Colorectal Cancer Metastatic to the Liver: A Retrospective AnalysisPatrick W Doyle, C Spencer Workman, Neal Shah, et al.Journal of Vascular and Interventional Radiology : JVIR|June 30, 2009
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteriaDaniel B Brown, Jennifer E Gould, Debra A Gervais, et al.Journal of Vascular and Interventional Radiology : JVIR|December 7, 2007
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteriaDaniel B Brown, Jennifer E Gould, Debra A Gervais, et al.Journal of Vascular and Interventional Radiology : JVIR|April 4, 2021
Multicenter Evaluation of Survival and Toxicities of Hepatocellular Carcinoma following Radioembolization: Analysis of the RESiN RegistryShelby Frantz, Lea Matsuoka, Kirubahara Vaheesan, et al.Journal of Vascular and Interventional Radiology : JVIR|December 12, 2022
Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN RegistryTaylor J Robinson, Liping Du, Lea Matsuoka, et al.Journal of Vascular and Interventional Radiology : JVIR|December 8, 2022
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular CarcinomaHannah C Hund, Shelby K Frantz, Hui Wu, et al.Journal of Vascular and Interventional Radiology : JVIR|November 1, 2019
Neutrophil/Lymphocyte Ratio Predicts Increased Risk of Immediate Progressive Disease following Chemoembolization of Hepatocellular CarcinomaJeffrey C Cruz, Jennifer M Watchmaker, Matthias M Albin, et al.Pageof 12